BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9683850)

  • 1. Advances in the understanding of human soft tissue sarcomas: molecular biology and therapeutic strategies (Review).
    Milas M; Yu D; Pollock RE
    Oncol Rep; 1998; 5(5):1275-9. PubMed ID: 9683850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical experimental therapeutic approaches in soft tissue sarcoma.
    Hunt KK; Feig BW
    Semin Surg Oncol; 1999; 17(1):78-82. PubMed ID: 10402641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-Line Therapy for Metastatic Soft Tissue Sarcoma.
    Meyer M; Seetharam M
    Curr Treat Options Oncol; 2019 Jan; 20(1):6. PubMed ID: 30675651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determinants of soft tissue sarcoma proliferation.
    Pollock RE
    Semin Surg Oncol; 1994; 10(5):315-22. PubMed ID: 7997725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic considerations: how can we fine tune our approach to sarcoma?
    Demicco EG; Lazar AJ
    Semin Oncol; 2011 Oct; 38 Suppl 3():S3-18. PubMed ID: 22055969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the diagnosis and management of sarcomas.
    Elias AD
    Curr Opin Oncol; 1991 Aug; 3(4):671-6. PubMed ID: 1932226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcomas.
    HaDuong JH; Martin AA; Skapek SX; Mascarenhas L
    Pediatr Clin North Am; 2015 Feb; 62(1):179-200. PubMed ID: 25435119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
    Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
    Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
    Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
    Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas.
    Drobnjak M; Latres E; Pollack D; Karpeh M; Dudas M; Woodruff JM; Brennan MF; Cordon-Cardo C
    J Natl Cancer Inst; 1994 Apr; 86(7):549-54. PubMed ID: 8133539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More Than 50 Subtypes of Soft Tissue Sarcoma: Paving the Path for Histology-Driven Treatments.
    Katz D; Palmerini E; Pollack SM
    Am Soc Clin Oncol Educ Book; 2018 May; 38():925-938. PubMed ID: 30231352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of soft tissue tumors.
    van de Rijn M; Fletcher JA
    Annu Rev Pathol; 2006; 1():435-66. PubMed ID: 18039122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.
    Todd R; Lunec J
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):939-48. PubMed ID: 18533803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soft tissue sarcoma of the upper extremity.
    Murray PM
    Hand Clin; 2004 Aug; 20(3):325-33, vii. PubMed ID: 15275691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft-Tissue Sarcomas: An Update for Radiologists Based on the Revised 2013 World Health Organization Classification.
    Baheti AD; O'Malley RB; Kim S; Keraliya AR; Tirumani SH; Ramaiya NH; Wang CL
    AJR Am J Roentgenol; 2016 May; 206(5):924-32. PubMed ID: 26998884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular heterogeneity. Explanation for changing of tumor phenotype and biologic behavior in soft tissue sarcomas.
    Katenkamp D
    Pathol Res Pract; 1988 Nov; 183(6):698-705. PubMed ID: 2851775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoma.
    Skubitz KM; D'Adamo DR
    Mayo Clin Proc; 2007 Nov; 82(11):1409-32. PubMed ID: 17976362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic and Immunohistochemical Analyses of Soft Tissue Sarcomas From brca2-Mutant/ tp53-Mutant Zebrafish Are Consistent With Neural Crest (Schwann Cell) Origin.
    White LA; Sexton JM; Shive HR
    Vet Pathol; 2017 Mar; 54(2):320-327. PubMed ID: 27879444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in sarcoma gene mutations and therapeutic targets.
    Gao P; Seebacher NA; Hornicek F; Guo Z; Duan Z
    Cancer Treat Rev; 2018 Jan; 62():98-109. PubMed ID: 29190505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What is the value of recent molecular biology knowledge for surgical oncologic therapy of soft tissue sarcoma?].
    Willeke F
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():393-8. PubMed ID: 9931648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.